Rescription
Scott Martin is an accomplished entrepreneur with extensive experience in the healthcare and employee benefits sectors. As the Founder and CEO of Rescription since October 2021, Scott has developed a model aimed at transforming prescription drug delivery and reducing costs for employees. Prior to this, Scott served as Chairman, CEO, and Founder of Remedy Analytics from October 2011 to October 2021, where innovative analytics technology was created to empower employers in managing prescription benefits effectively. Scott's career includes founding and leading MBC, Inc. and MBHR, Inc., which were sold to Brown & Brown, and holding executive roles at Oxford Health Plans and Carrington Laboratories. Scott holds a Bachelor's Degree in English with a Minor in History from Hobart and William Smith Colleges.
This person is not in any teams
Rescription
Rescription is a next-generation full PBM solution that leverages health system partnerships to deliver pharmacy benefits at net costs 20-40% lower than any alternative, without the need to limit patient drug choice. Rescription fully supports the change from a traditional PBM to its model, including claim servicing, administrative, and retail network infrastructure. It leverages your pharmacy, specialists, and 340B purchasing capabilities to create a preferred network for patients and their families. All drugs are passed through at their sourced price and Rescription simply charges a subscription-based fee per member, meaning that Rescription's only financial incentive is to save its clients and partners money on their prescription drug costs. Health systems can learn more about prescription drug savings opportunities at www.rescription.com.